Categories: All postsCannabis

OrganiGram is a cheap pot stock, says Beacon Securities

Beacon Securities analyst Russell Stanley says that not only is cannabis name OrganiGram Holdings (OrganiGram Holdings Stock Quote, Chart TSXV:OGI) currently trading at a substantial discount to its broader peer group, on a technical basis the stock is now trading at levels that should offer strong support.

On Tuesday, Moncton, New Brunswick-based OrganiGram announced that it had entered into an exclusive agreement allowing it to license Feather Company’s proprietary vaporizer pen technology and form factor, with management contending that the technology targets the more sophisticated cannabis consumer.

In an update to clients Tuesday, Stanley said OGI is well-positioned as a partner of choice for the agreement, as it is one of a select few companies with sales relationships in all ten Canadian provinces. The analyst also says that once Cannabis 2.0 comes into effect this fall, he expects vape products to be a major sales driver across Canada, as they represent greater than 20 per cent of sales in US states with rec and/or medical legalization.

“OGI is now trading at 12x our C2020E EBITDA estimate (which is a weighted average of our F2020 and F2021 estimates, given OGI’s August 31 FYE). This represents a 49 per cent discount to the 23x average for the broad peer group, and a 61 per cent discount to the 30x average amongst companies that trade on either NASDAQ or NYSE,” said Stanley.

The analyst says that upcoming potential catalysts for OGI include the company’s third quarter results in July, continued expansion updates and additional news on product development. Stanley is maintaining his “Buy” rating and $15.00 target price for OGI, which represents a projected return of 80 per cent at the time of publication.

Stanley thinks OrganiGram will generate fiscal 2019 revenue and adjusted EBITDA of $107.1 million and $54.3 million, respectively, and fiscal 2020 revenue and adjusted EBITDA of $218.8 million and $111.2 million, respectively.

More Cantech Cannabis

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: ogi
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

3 hours ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

5 hours ago

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

21 hours ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

1 day ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

1 day ago

Is Wolfspeed stock still a buy?

Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]

1 day ago